Cargando…
Correction: Efficacy of Bifidobacterium animalis subsp. lactis (BB-12), B. infantis and Lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study Protocol
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511619/ https://www.ncbi.nlm.nih.gov/pubmed/32948579 http://dx.doi.org/10.1136/bmjopen-2019-032617corr1 |
Ejemplares similares
-
Efficacy of Bifidobacterium animalis subsp. lactis (BB-12), B. infantis and Lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study Protocol
por: Marißen, Janina, et al.
Publicado: (2019) -
Microencapsulation of Bifidobacterium animalis subsp. lactis and Lactobacillus acidophilus in cocoa butter using spray chilling technology
por: Pedroso, D.L., et al.
Publicado: (2014) -
The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)
por: Jungersen, Mikkel, et al.
Publicado: (2014) -
Germinated brown rice combined with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis inhibits colorectal carcinogenesis in rats
por: Lin, Pao‐Ying, et al.
Publicado: (2018) -
Updated Genome Sequence for the Probiotic Bacterium Bifidobacterium animalis subsp. lactis BB-12
por: Jensen, Kristian, et al.
Publicado: (2021)